Bain & Company's research suggests that surgeons at ASCs are more likely to change medical devices than their peers within hospital settings.
Beginning in 2012, average year-over-year hospital costs have grown at a rate exceeding revenue growth. Pressure to maintain healthcare spending continues to intensify and supply chain costs have reached an all-time high.
The FDA’s Alternative Summary Reporting Program allowed inefficient reporting of injuries and deaths caused by medical device malfunction, and hid decades worth of important device data from doctors and the public.
In this week's Advisor Spotlight, Relatable Healthcare would like to introduce Steve Seigel.
Steve Seigel is a Los Angeles-based technology entrepreneur and investor.